𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Deletion mapping of chromosome 2 in human lung carcinoma

✍ Scribed by Toshiyuki Otsuka; Takashi Kohno; Masatomo Mori; Masayuki Noguchi; Setsuo Hirohashi; Jun Yokota


Publisher
John Wiley and Sons
Year
1996
Tongue
English
Weight
562 KB
Volume
16
Category
Article
ISSN
1045-2257

No coin nor oath required. For personal study only.

✦ Synopsis


Sixty-three non-small cell lung carcinomas (NSCLCs) and 20 small cell lung carcinomas (SCLct) were examined for loss of heterozygosity (LOH) on chromosome 2. Fifteen highly polymorphic dinucleotide markers spanning both the short and long arms of chromosome 2 were selected for a polymerase chain reaction (PCR)-based fine mapping. They included a DNA marker localized in the homozygously deleted region at 2q33, which we previously identified in an SCLC cell line. LOH on chromosome arm 2q was detected in 23/63 (37%) of NSCLC and 6/20 (30%) of SCLC, while LOH on 2p was observed in 14/56 (25%) and 4/ I7 (24%), respectively. There were two commonly deleted regions mapped to 2q32-q37 and 2p I6-pter, and the homoqgously deleted region at 2q33 was in the commonly deleted region on 2q. In NSCLC, the incidence of LOH on 2p and 2q was significantly higher in brain metastases than in primary tumors (P = 0.005 and 0.001, respectively). In addition, LOH on chromosome arm 2q occurred more frequently in moderately/poorly differentiated tumors than in well-differentiated tumors (P = 0.046). These results suggested that inactivation of tumor suppressor genes on chromosome 2 is involved in the phenotypic alterations of NSCLC cells into more aggressive ones.


πŸ“œ SIMILAR VOLUMES


Fine deletion mapping of chromosome 8p i
✍ Florence Lerebours; Sylviane Olschwang; BΓ©nΓ©dicte Thuille; Annette Schmitz; Pier πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 French βš– 180 KB πŸ‘ 2 views

Several somatic genetic alterations have been described in non-small-cell lung carcinomas (NSCLC). Recurrent chromosomal deletions have suggested the presence of tumor-suppressor genes specifically involved in lung carcinogenesis. For one of these, 2 non-overlapping regions have been proposed on the

Deletion mapping of chromosome 4q in hep
✍ Zhe Piao; Chanil Park; Jeon-Han Park; Hoguen Kim πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 French βš– 162 KB πŸ‘ 2 views

Hepatocellular carcinoma (HCC) frequently shows a loss of heterozygosity (LOH) on chromosome 4q. In order to define the commonly affected region on chromosome 4q for further positional cloning of the putative tumor suppressor gene, we carried out allelic imbalance (AI) studies in 41 HCCs using a pan

Deletion mapping of chromosome 19 in hum
✍ Andreas von Deimling; Judith Nagel; Bernhard Bender; Doris Lenartz; Johannes Sch πŸ“‚ Article πŸ“… 1994 πŸ› John Wiley and Sons 🌐 French βš– 762 KB

## Abstract There is evidence that a putative glioma tumor suppressor locus resides on the long arm of chromosome 19. We present data on 161 gliomas from IS6 patients, which were studied by microsatellite analysis for loss of heterozygosity (LOH) on chromosome 19. Eight loci on the long arm and 2 l

Deletion mapping of chromosomes 8, 10, a
✍ Ulf S. R. Bergerheim; Kazuto Kunimi; Dr. V. Peter Collins; Peter Ekman πŸ“‚ Article πŸ“… 1991 πŸ› John Wiley and Sons 🌐 English βš– 738 KB

In an allelotyping study of prostatic carcinoma, we found the highest frequency of allelic deletions on chromosomes 8, 10, 16, and 18. In all cases with allelic deletions, at least one of the chromosomes 8, 10, and 16 were involved. A detailed deletion mapping of these chromosomes in I 8 cases was c

Deletion mapping of the short arm of chr
✍ Hiroyuki Ohata; Mitsuru Emi; Yoshiyuki Fujiwara; Kazuya Higashino; Ken Nakagawa; πŸ“‚ Article πŸ“… 1993 πŸ› John Wiley and Sons 🌐 English βš– 309 KB

Frequent losses of heterozygosity observed at several chromosomal loci in primary lung cancers have indicated the existence of several tumor suppressor genes associated with this type of cancer. We have examined loss of heterozygosity on chromosomal arm 8p in 49 cases of non-small cell lung carcinom